Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Not Confirmed
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Not Confirmed
Not Confirmed
28 October-01 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Industry Trade Show
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Industry Trade Show
Not Confirmed
28 October-01 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-have-built-considerable-expertise-in-glp-1-drug-development-through-our-oral-peptide-programs
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
24 Oct 2024
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/merck-buys-cancer-therapy-developer-modifi-biosciences-up-13-bln-2024-10-23/
16 Oct 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/10/16/2760474/0/en/Modifi-Bio-Raises-Additional-4-3-Million-in-Seed-Funding.html
13 Dec 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/12/13/2572758/0/en/Modifi-Bio-Announces-Scientific-Advisory-Board.html
Details:
The financing will be used to further advance Modifi bio's lead molecules towards IND-enabling studies and phase I clinical trials. It works in DNA modification as a novel approach to target cancer.
Lead Product(s): Undisclosed
Therapeutic Area: Oncology Brand Name: Undisclosed
Study Phase: PreclinicalProduct Type: Undisclosed
Sponsor: Connecticut Innovation
Deal Size: $10.7 million Upfront Cash: Undisclosed
Deal Type: Financing October 16, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : Connecticut Innovation
Deal Size : $10.7 million
Deal Type : Financing
Modifi Bio Raises Additional $4.3 Million in Seed Funding
Details : The financing will be used to further advance Modifi bio's lead molecules towards IND-enabling studies and phase I clinical trials. It works in DNA modification as a novel approach to target cancer.
Brand Name : Undisclosed
Molecule Type : Undisclosed
Upfront Cash : Undisclosed
October 16, 2023
Details:
The grant will support drug development around a class of molecules targeting cancer cells lacking expression of key DNA repair protein called MGMT (O6-methylguanine methyl transferase), based on a recent publication from the Yale founders’ laboratories in Science.
Lead Product(s): Undisclosed
Therapeutic Area: Oncology Brand Name: Undisclosed
Study Phase: PreclinicalProduct Type: Undisclosed
Sponsor: National Cancer Institute
Deal Size: $2.4 million Upfront Cash: Undisclosed
Deal Type: Funding October 25, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : National Cancer Institute
Deal Size : $2.4 million
Deal Type : Funding
Details : The grant will support drug development around a class of molecules targeting cancer cells lacking expression of key DNA repair protein called MGMT (O6-methylguanine methyl transferase), based on a recent publication from the Yale founders’ laboratorie...
Brand Name : Undisclosed
Molecule Type : Undisclosed
Upfront Cash : Undisclosed
October 25, 2022
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?